3.3. Ibrutinib Monotherapy Inhibits B Cell Infiltration and Activation in Mouse Orthotopic PCa Models, but Augments CD8+ T Cells with High Expression of Inhibitory Receptors (IRs) and Fails to Control Tumor Progression. The gene discussed is CD8A; the disease is neoplasm.